Menu
Amrit Mahotsav Logo
International Year of Cooperatives Logo

Important Document

Important Document

Sr. No. Title Details
301 Hiring of Non Technical Consultant (SO Level) on contract basis
302 Major achievements during May, 2018 - IC Section
303 Promotion of International Day of Yoga (IDY) from 21st May 2018 onwards - regarding
    304 Hiring of consultant on contract basis
    305 31th Steering Committee Meeting of NIPERs
    306 Major achievements during March 2018 -IC Section
    307 Corrigundum-Hiring of One Principal Legal Consultant in NPPA on contract basis
    308 Invoking Para 3 of DPCO, 2013 under acute shortage of formulation Viraferonpeg 100 mcg Injection
    309 Hiring of One Principal Legal Consultant in NPPA on contract basis
    310 Hiring of seven (07) Senior/Principal Associates in NPPA on contract basis
    311 Recruitment of Chief Executive Officer (CEO) in BPPI
    312 List of 3rd India Pharma/Medical Device Awards
    313 Statement of Accounts of NIPER Hyderabad 2014-15
      314 Statement of Accounts of NIPER S.A.S. Nagar 2015-16
        315 Statement of Accounts of NIPER S.A.S. Nagar 2014-15
          316 Disposal of unserviceable/condemned staff car DL-2CQ 0769.
          317 Major achievements during October 2017 - IC Section
          318 Last date for receipt of nomination of 3rd India Pharma/Medical Device Awards was 31.10.2017. It has been further extended upto 30.11.2017.
          319 3rd India Pharma / Medical Device Awards
          320 Hiring of Consultant(Hindi) in NPPA on contract basis.
            321 Hiring of Principal Legal Consultant in NPPA on contract basis
            322 Request for Proposal for Publicity Activities for the Schemes of Department of Pharmaceuticals -Regarding
            323 Nomination of 3rd India Pharma Awards and Medical Device Awards has been extended upto 31.10.2017.
            324 Request for Proposal for Publicity Activities for the Schemes of Department of Pharmaceuticals
            325 Ensuring compliance of the price capping of the Coronary Stents along with maintaining its uninterrupted supply -regarding
            326 Ensuring compliance of the price capping of the Primary Knee and Revision Knee along with maintaining its uninterrupted supply -regarding
            327 Hiring of Senior Consultants and Consultant in NPPA on contract basis
            328 Message of Honorable Secretary Department of Pharmaceuticals on Hindi Day
            329 Report of Department of Pharmaceuticals on Swachhata Pakhwada During 16-31st August 2017
            330 Major achievements during August 2017 IC Section
            331 Message from Honorable Minister (C&F) on Swachhta Pakhwada
            332 Message from Honorable MOS (C&F) on Swachhta Pakhwada
            333 FAQs on GST on drugs and Pharmaceuticals
            334 3rd India Pharma Awards and Medical Device Awards
            335 Minutes of 28th Steering Committee Meeting
            336 Shortage of Pencillamine medicine used for treatment of Wilsons disease - regarding
            337 Appointment of Part - time CVO in Department of Pharmaceuticals
            338 Constitution of GST Facilitation Cell
            339 Application for the post of Director, Niper, Hyderabad
            340 Application form of Technical and Legal Consultant on contract basis
            341 Hiring of Technical consultant and Legal consultant on contract- reg.
            342 Hiring of Technical consultant and Legal consultant on contract- reg.
            343 Implementation of prices fixed and notified under the provisions of DPCO, 2013 - reg.
            344 Minutes of the Meeting held on 09.05.2017 in the Department of Pharmaceuticals regarding preparation of Calendar of Events for organizing Conferences/Seminars/Workshops under Pharmaceutical Promotion and Development Scheme- PPDS
            345 Meeting regarding Grant-in-aid under Pharmaceuticals Promotion & Development Scheme (PPDS)
            346 Composition of NPPA Authority- Regarding
            347 Shortage of Pencillamine medicine used for treatment of Wilsons disease - regarding
            348 Fixation of ceiling price of a scheduled formulation under Para 4 of Drugs (Prices Control) Order, 2013 (DPCO, 2013) - regarding.
            349 Submission of the detailed agreement/contract between the manufacturer and marketer to NPPA. - regarding
            350 Implementation of prices fixed and notified under the provisions of DPCO, 2013 - reg.

            Pages